---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-155116"
form_type: "8-K"
ticker: "COGT"
cik: "0001622229"
company_name: "Cogent Biosciences, Inc."
filed_at: "2024-06-05T23:59:59+00:00"
generated_at: "2026-06-01T06:16:40.563413+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cogent Biosciences shareholders approve doubling authorized common stock to 300M shares

## Summary
- Amendment increases authorized common shares from 150M to 300M; total authorized shares from 160M to 310M.
- Outdated reverse stock split provisions deleted from the certificate of incorporation.
- All three director nominees elected; Andrew Robbins received 67.8M for, Peter Harwin received 51.7M for.
- Advisory vote on executive compensation passed with 69.6M for vs 6.7M against; future votes set for annual frequency.

## SEC filing metadata
- accession: 0001193125-24-155116
- form_type: 8-K
- ticker: COGT
- cik: 0001622229
- company_name: Cogent Biosciences, Inc.
- filed_at: 2024-06-05T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1622229/000119312524155116/0001193125-24-155116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1622229/000119312524155116/d805683d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-155116
- JSON: https://secwatch.observer/filing/0001193125-24-155116.json
- Plain text: https://secwatch.observer/filing/0001193125-24-155116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.